Next Article in Journal
Collision Avoidance Using Finite Control Set Model Predictive Control for Unmanned Surface Vehicle
Previous Article in Journal
Online State of Health Estimation for Lithium-Ion Batteries Based on Support Vector Machine
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessArticle
Appl. Sci. 2018, 8(6), 924;

Compound K Inhibits the Lipopolysaccharide-Induced Inflammatory Responses in Raw 264.7 Cell Line and Zebrafish

Department of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam, Kyonggi 463-400, Korea
National Institute of Biological Resources, Incheon 404-170, Korea
Department of Food and Nutrition, Seoul Women’s University 621, Hwarang-ro, Nowon-gu, Seoul 01797, Korea
These authors contributed equally to this work.
Authors to whom correspondence should be addressed.
Received: 21 April 2018 / Revised: 1 June 2018 / Accepted: 1 June 2018 / Published: 4 June 2018
(This article belongs to the Section Chemistry)
Full-Text   |   PDF [2035 KB, uploaded 4 June 2018]   |  


Compound K, a major metabolite of ginsenosides Rb1, which is produced by human intestinal bacteria after oral administration, is one of the main pharmacologic compounds found in ginseng. In our previous study, we demonstrated that compound K inhibited the production of nitric oxide (NO) and prostaglandin E2 in lipopolysaccharide (LPS)-treated RAW264.7 cells. However, the mechanisms by which compound K may be effective against inflammation remain unknown. In the present study, compound K significantly inhibited LPS-induced NO production by suppression of inducible NO synthase (iNOS) in LPS-treated RAW264.7 cells. Compound K also inhibited LPS-induced cyclooxygenase-2 (COX-2) expression at both the mRNA and protein levels. It effectively suppressed both the release and mRNA expression levels of pro-inflammatory cytokines such as interleukin-1β (IL-1β) and IL-6. The anti-inflammatory effects of compound K appeared to occur via inhibition of LPS-induced phosphorylation of mitogen-activated protein kinases (MAPKs) and inhibition of NF-κB translocation from the cytosol to the nucleus by suppressing phosphorylation of inhibitory kappa B-α (IκB-α). Furthermore, we showed that compound K inhibited LPS-induced NO generation in an experimental zebrafish model. Considering these results, compound K could potentially be developed as a natural anti-inflammatory agent. View Full-Text
Keywords: compound K; RAW264.7 cell; zebrafish; NF-κB(p-65); MAPK compound K; RAW264.7 cell; zebrafish; NF-κB(p-65); MAPK

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Ryu, S.-J.; Choi, J.; Lee, J.-S.; Choi, H.-S.; Yoon, K.-Y.; Hwang, J.-H.; Kim, K.J.; Lee, B.-Y. Compound K Inhibits the Lipopolysaccharide-Induced Inflammatory Responses in Raw 264.7 Cell Line and Zebrafish. Appl. Sci. 2018, 8, 924.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Appl. Sci. EISSN 2076-3417 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top